Tecon Pharmaceutical Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 912

Employees

  • Latest Deal Type
  • IPO
  • (Cancelled)

  • Investors
  • 5

Tecon Pharmaceutical General Information

Description

Producer of veterinary biological products designed to prevent and control major animal diseases in livestock and poultry. The company develops and manufactures a comprehensive range of vaccines for swine, ruminants, and poultry, including foot-and-mouth disease and highly pathogenic avian influenza vaccines, enabling agricultural enterprises and veterinarians to ensure livestock health and biosecurity.

Contact Information

Formerly Known As
Tecon Pharmaceutical (Suzhou) Co., Ltd.
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • No. 77, Jianpu Road
  • Suzhou Industrial Park
  • Suzhou, Jiangsu 215000
  • China
+86 0512
Primary Industry
Other Agriculture
Other Industries
Other Pharmaceuticals and Biotechnology
Corporate Office
  • No. 77, Jianpu Road
  • Suzhou Industrial Park
  • Suzhou, Jiangsu 215000
  • China
+86 0512

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tecon Pharmaceutical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. IPO 31-Jul-2026 Cancelled Profitable
2. IPO 22-Dec-2023 Completed Profitable
1. Later Stage VC 12-Oct-2022 $233M $233M Completed Profitable
To view Tecon Pharmaceutical’s complete valuation and funding history, request access »

Tecon Pharmaceutical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
To view Tecon Pharmaceutical’s complete cap table history, request access »

Tecon Pharmaceutical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tecon Pharmaceutical Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
China New Populus Euphratica Private Equity Fund Growth/Expansion Minority
CITIC Securities Investment Company Corporate Venture Capital Minority
Finnova Capital Venture Capital Minority
Shenzhen Capital Group Venture Capital Minority
Suzhou Yuanfeng Capital Management Government Minority
To view Tecon Pharmaceutical’s complete investors history, request access »

Tecon Pharmaceutical FAQs

  • When was Tecon Pharmaceutical founded?

    Tecon Pharmaceutical was founded in 2018.

  • Where is Tecon Pharmaceutical headquartered?

    Tecon Pharmaceutical is headquartered in Suzhou, China.

  • What is the size of Tecon Pharmaceutical?

    Tecon Pharmaceutical has 912 total employees.

  • What industry is Tecon Pharmaceutical in?

    Tecon Pharmaceutical’s primary industry is Other Agriculture.

  • Is Tecon Pharmaceutical a private or public company?

    Tecon Pharmaceutical is a Private company.

  • What is Tecon Pharmaceutical’s current revenue?

    The current revenue for Tecon Pharmaceutical is .

  • How much funding has Tecon Pharmaceutical raised over time?

    Tecon Pharmaceutical has raised $233M.

  • Who are Tecon Pharmaceutical’s investors?

    China New Populus Euphratica Private Equity Fund, CITIC Securities Investment Company, Finnova Capital, Shenzhen Capital Group, and Suzhou Yuanfeng Capital Management have invested in Tecon Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process